Ecovia Announces Appointment of Terry Papoutsakis to Scientific Advisory Board

ANN ARBOR, MICHIGAN, September 10th, 2019— Ecovia Renewables Inc., a Michigan-based biotechnology company focused on the research and development of high-performing biobased materials and ingredients, is pleased to announce the appointment of Eleftherios (Terry) Papoutsakis to its Scientific Advisory Board. Dr. Papoutsakis brings invaluable experience to early-stage biotechnology development and will lend his expertise to advance Ecovia’s core strategy of bringing high-value biobased products to market.


Dr. Papoutsakis is the Unidel Eugene DuPont Professor at the Dept. of Chemical & Biomolecular Engineering and the Dept. of Biological Sciences at the University of Delaware. Dr. Papoutsakis’ group has made important contributions in both microbial and animal-cell biotechnology. Microbial biotechnology work includes contributions in clostridia genetics and metabolic engineering with emphasis in syntrophic co-cultures and E. coli biotechnology including synthetic methylotrophy and stress tolerance. Animal-cell biotechnology includes seminal work on mixing and agitation in cell-culture bioreactors, and stem-cell bioengineering with emphasis on hematopoietic engineering and the use of extracellular vesicles for applications in cell and gene therapies.

He has been recognized by numerous awards, including election to the National Academy of Engineering (USA), the 2020 American Society of Microbiology (ASM) Award for Applied and Biotechnological Research, the 2017 American Chemical Society (ACS) E. V. Murphree Award in Industrial and Engineering Chemistry, the 2013 DIC Wang Award for Excellence in Biochemical Engineering, SBE/AIChE (Soc. Biological Eng.; Amer. Institute of Chem. Engineers), the 2012 James E. Bailey Award, SBE/AIChE; election as Fellow of ACS (2011), the 2010 Metabolic Engineering Award, the 2005 Amgen Biochemical Engineering Award, the 2004 Merck Cell Culture Engineering Award & the 2003 Alpha Chi Sigma AIChE Award. He received his BS/MS in Chemical Engineering from the National Technical University of Athens; MS/PhD in Chemical Engineering from Purdue University. He has supervised over 60 PhD, 30 MS, 32 postdoctoral and 70 undergraduate research students, funded by over $40 million in grants from NSF, NIH, DOE, ARPA-E, ONR, ARO & EPA. 

Dr. Papoutsakis joins Dr. Nina Lin of the University of Michigan on Ecovia’s Scientific Advisory Board.


About Ecovia Renewables Inc.

Ecovia Renewables Inc. is a privately-held biotechnology company focused on the research and development of high-performing biobased ingredients and materials. It was spun-out from the University of Michigan in 2014, inspired by Dr. Nina Lin and Dr. Jeremy Minty’s pioneering research on engineering custom microbial systems.